BMJ · 1956 · 14 citations · 6 references
MedicinePharmacologyPsychiatryClinical PharmacologyNeuropharmacologyPsychopharmacologyAnxiety Disorder PharmacotherapyAnxiolytic PharmacotherapyAnxiolytic TherapyPsychiatric Effects Of MedicationsAnxiety In Chronic IllnessAnxiolytic MedicationsBarbiturate TherapyBarbiturate ToxicityPharmacologic AnxiolysisPharmacologic Treatment Of WithdrawalPharmacological Management Of WithdrawalPsychiatric Manifestations
~~~~MEDICAL JOURNAL These results seem to indicate that if either drug is given for short periods to most patients with anxiety and tension about equal benefit will accrue. Some few patients do benefit, however, from meprobamate only and others from sodium amylobarbitone only.
6
Ralph V. Ford, John C. Madison, John H. Moyer · The American Journal of the Medical Sciences · 1956 · 23 citations